Nano-systems for advanced therapeutics and diagnosis of atherosclerosis

C Gaurav, B Saurav, R Goutam… - Current Pharmaceutical …, 2015 - ingentaconnect.com
Cardiovascular diseases (CVDs) are the leading cause of death and morbidity worldwide.
Atherosclerotic situations such as acute myocardial infarction (MI) and stroke are still major …

Current status of nanotechnology approaches for cardiovascular disease: a personal perspective

DB Buxton - Wiley Interdisciplinary Reviews: Nanomedicine …, 2009 - Wiley Online Library
Nanotechnology is poised to have an increasing impact on cardiovascular health in coming
years. Diagnostically, multiplexed point‐of‐care devices will enable rapid genotyping and …

Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology

SA Wickline, AM Neubauer, P Winter… - … , and vascular biology, 2006 - Am Heart Assoc
The role of nanotechnology in cardiovascular diagnosis is expanding rapidly. The goal of
this brief review is to illustrate selected examples of nanosystems that have been applied to …

[PDF][PDF] Emerging nanoparticles in the diagnosis of atherosclerosis

T Kataria, MS Hussain, G Kaur… - International Journal of …, 2021 - researchgate.net
Throughout the last few decades, cardiovascular research has substantially advanced our
awareness of the atherosclerotic process, the molecular processes underlying the disease …

New insights to atherosclerosis management: Role of nanomaterials

Z Li, C Jiang, L Chai, T Fan, C Li, Z Chen… - Applied Materials …, 2022 - Elsevier
Atherosclerosis is a sort of chronic inflammatory disease mainly caused by the accumulation
of lipoproteins on the blood vessel walls. Many cardiovascular diseases with high mortality …

Nanotechnology in diagnosis and treatment of coronary artery disease

M Karimi, H Zare, A Bakhshian Nik, N Yazdani… - …, 2016 - Taylor & Francis
Nanotechnology could provide a new complementary approach to treat coronary artery
disease (CAD) which is now one of the biggest killers in the Western world. The course of …

[HTML][HTML] Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective

A Nakhlband, M Eskandani, Y Omidi, N Saeedi… - BioImpacts …, 2018 - ncbi.nlm.nih.gov
An external file that holds a picture, illustration, etc. Object name is bi-8-59-g004. jpg
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …

Atherosclerosis and nanomedicine potential: current advances and future opportunities

F Jiang, Y Zhu, C Gong, X Wei - Current Medicinal Chemistry, 2020 - ingentaconnect.com
Atherosclerosis is the leading inducement of cardiovascular diseases, which ranks the first
cause of global deaths. It is an arterial disease associated with dyslipidemia and changes in …

Nanomedicine for atherosclerosis: molecular imaging and treatment

V Karagkiozaki, S Logothetidis… - Journal of biomedical …, 2015 - ingentaconnect.com
Cardiovascular diseases (CVDs) and the underlying process of atherosclerosis are
considered to be the most frequent causes of mortality and morbidity in developed societies …

Nanomedicine approaches for advanced diagnosis and treatment of atherosclerosis and related ischemic diseases

B Hu, KO Boakye‐Yiadom, W Yu… - Advanced …, 2020 - Wiley Online Library
Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …